Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)
CNY 23.35
(-1.39%)
CNY 23.35
(-1.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 971.87 Million | 285.68 Million | 1.03 Billion | 238.65 Million | 405.95 Million | 499.39 Million |
| Net Income | 581.19 Million | 469.5 Million | 710.82 Million | 405.91 Million | 364.38 Million | 317.44 Million |
| Depreciation & Amortization | 95.77 Million | 83.18 Million | 65.83 Million | 43.56 Million | 36.03 Million | 23.14 Million |
| Deferred income taxes | -24.25 Million | -8.33 Million | 38.78 Million | -16.19 Million | -3.04 Million | 4.21 Million |
| Stock-based compensation | 394.58 Thousand | 1.29 Million | 4.89 Million | 9.58 Million | 14.04 Million | - |
| Change in working capital | 47.79 Million | -374.72 Million | 521.05 Million | -303 Million | 3.43 Million | 190.9 Million |
| Other non-cash items | 439.62 Million | 112.45 Million | -306.47 Million | 98.78 Million | -8.9 Million | -32.09 Million |
| Investing Cash Flow | -589.65 Million | -334.49 Million | -2.15 Billion | -592.25 Million | 377.85 Million | -95.52 Million |
| Investments in PPE | -234.81 Million | -272.39 Million | -125.57 Million | -338.97 Million | -52.27 Million | -128.94 Million |
| Acquisitions | -563.38 Thousand | -3.83 Million | -61.11 Million | 339.27 Million | 54.17 Million | - |
| Investment purchases | -1.49 Billion | -1.41 Billion | -3.49 Billion | -830 Million | -300 Million | -1.55 Billion |
| Sales/Maturities of investments | 1.13 Billion | 1.35 Billion | 1.52 Billion | 576.41 Million | 728.21 Million | 1.58 Billion |
| Other Investing Activities | -75.77 Million | 3.83 Million | 1500.61 | -338.96 Million | -52.27 Million | 4940.11 |
| Financing Cash Flow | -431.89 Million | -183.22 Million | -42.75 Million | 839 Million | 166.2 Million | -262.48 Million |
| Debt repayment | -201.8 Million | -637.79 Million | -341.84 Million | -450 Million | -300 Million | -385 Million |
| Dividends payments | -206.72 Million | -312.78 Million | -180.12 Million | -185.56 Million | -166.44 Million | -175.25 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -13.32 Million | 795.08 Million | 494.62 Million | 1.48 Billion | 633.33 Million | 297.76 Million |
| Accounts receivables | 41.95 Million | -209.3 Million | 369.7 Million | -349.1 Million | -101.96 Million | 110.54 Million |
| Accounts payables | 9.78 Million | -146.43 Million | 136.59 Million | 94.45 Million | 110.34 Million | 82.74 Million |
| Inventory | -28.45 Million | -10.64 Million | -24.03 Million | -32.4 Million | -1.89 Million | -9.17 Million |
| Other working capital | 24.5 Million | -8.33 Million | 38.78 Million | -15.94 Million | -3.04 Million | 200.07 Million |
| Cash at beginning of period | 437.57 Million | 666.63 Million | 1.83 Billion | 1.34 Billion | 395.51 Million | 254.12 Million |
| Cash at end of period | 403.43 Million | 437.57 Million | 666.63 Million | 1.82 Billion | 1.34 Billion | 395.51 Million |
| Capital Expenditure | -234.81 Million | -272.39 Million | -125.57 Million | -338.97 Million | -52.27 Million | -128.94 Million |
| Effect of forex changes on cash | 614.63 Thousand | 2.96 Million | -749.69 Thousand | -2.25 Million | 1.23 Million | - |
| Net cash flow / Change in cash | -34.13 Million | -229.06 Million | -1.16 Billion | 483.14 Million | 951.23 Million | 141.38 Million |
| Free Cash Flow | 737.05 Million | 13.28 Million | 909.34 Million | -100.31 Million | 353.68 Million | 370.45 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 228.22 Million | 97.46 Million | 200.69 Million | 581.19 Million | 68.23 Million |
| Depreciation & Amortization | - | 34.27 Million | 34.27 Million | 26.59 Million | 95.77 Million | -40.37 Million |
| Deferred income taxes | - | - | - | - | -24.25 Million | -427.46 Million |
| Stock-based compensation | - | - | - | 394.58 Thousand | 394.58 Thousand | -474.37 Thousand |
| Change in working capital | - | - | - | 38 Million | 47.79 Million | 461.42 Million |
| Other non-cash items | - | 47.65 Million | -288.78 Million | 561.83 Million | 439.62 Million | -170.46 Million |
| Investing Cash Flow | -474.85 Million | 422.74 Million | -276.88 Million | -46.07 Million | -589.65 Million | -99.92 Million |
| Investments in PPE | -9.64 Million | -146.75 Million | -46.9 Million | -128.51 Million | -234.81 Million | -41.37 Million |
| Acquisitions | - | - | - | -599.11 Thousand | -563.38 Thousand | 0.99 |
| Investment purchases | -632.46 Million | -453.24 Million | -540 Million | - | -1.49 Billion | -470 Million |
| Sales/Maturities of investments | 167.24 Million | 1.02 Billion | 310.02 Million | 83.04 Million | 1.13 Billion | 411.45 Million |
| Other Investing Activities | - | - | -229.97 Million | 1.00 | -75.77 Million | - |
| Financing Cash Flow | -269.58 Million | -146.06 Million | 435.84 Million | -615.94 Million | -431.89 Million | -156.89 Million |
| Debt repayment | - | -138.4 Million | -439.2 Million | -602.5 Million | -201.8 Million | -200.25 Million |
| Dividends payments | -270.75 Million | -5.85 Million | -2.97 Million | -206.72 Million | -206.72 Million | -206.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 1.17 Million | -5.47 Million | -382.87 Thousand | 203.32 Million | -13.32 Million | 249.44 Million |
| Accounts receivables | - | - | - | 41.95 Million | 41.95 Million | 435.67 Million |
| Accounts payables | - | - | - | - | 9.78 Million | - |
| Inventory | - | - | - | -28.45 Million | -28.45 Million | 25.75 Million |
| Other working capital | - | - | - | 24.5 Million | 24.5 Million | - |
| Cash at beginning of period | 874.64 Million | 357.24 Million | 388.5 Million | 223.9 Million | 437.57 Million | 590.08 Million |
| Cash at end of period | 315.87 Million | 875.74 Million | 356.2 Million | 403.43 Million | 403.43 Million | 223.9 Million |
| Capital Expenditure | -9.64 Million | -146.75 Million | -46.9 Million | -128.51 Million | -234.81 Million | -41.37 Million |
| Effect of forex changes on cash | -633.63 Thousand | 167.04 Thousand | 63.74 Thousand | -505.85 Thousand | 614.63 Thousand | -235.07 Thousand |
| Net cash flow / Change in cash | -558.77 Million | 518.5 Million | -32.3 Million | 179.52 Million | -34.13 Million | -366.18 Million |
| Free Cash Flow | -9.64 Million | 94.84 Million | -238.23 Million | 698.6 Million | 737.05 Million | -150.5 Million |
8447
WISA
LRLCY
0519
267250
002675